Search Results - "CARON, Nicholas"

Refine Results
  1. 1

    Therapeutic approaches to Huntington disease: from the bench to the clinic by Caron, Nicholas S., Dorsey, E. Ray, Hayden, Michael R.

    Published in Nature reviews. Drug discovery (01-10-2018)
    “…New therapies, including RNA-based and gene therapies, are poised to change the therapeutic landscape for Huntington disease. In this article, Hayden and…”
    Get full text
    Journal Article
  2. 2

    Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies by Wright, Galen E B, Black, Hailey Findlay, Collins, Jennifer A, Gall-Duncan, Terence, Caron, Nicholas S, Pearson, Christopher E, Hayden, Michael R

    Published in Lancet neurology (01-11-2020)
    “…Huntington's disease is a fatal neurodegenerative disorder that is caused by CAG-CAA repeat expansion, encoding polyglutamine, in the huntingtin (HTT) gene…”
    Get full text
    Journal Article
  3. 3

    Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells by Caron, Nicholas S, Munsie, Lise N, Keillor, Jeffrey W, Truant, Ray

    Published in PloS one (31-08-2012)
    “…Transglutaminase type 2 (TG2) is a ubiquitously expressed member of the transglutaminase family, capable of mediating a transamidation reaction between a…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease models by Sogorb-Gonzalez, Marina, Landles, Christian, Caron, Nicholas S, Stam, Anouk, Osborne, Georgina, Hayden, Michael R, Howland, David, van Deventer, Sander, Bates, Gillian P, Vallès, Astrid, Evers, Melvin

    Published in Brain (London, England : 1878) (15-10-2024)
    “…Abstract Huntington’s disease (HD) is a fatal neurodegenerative disease caused by a trinucleotide repeat expansion in exon 1 of the huntingtin gene (HTT) that…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice by Caron, Nicholas S., Banos, Raul, Aly, Amirah E., Xie, Yuanyun, Ko, Seunghyun, Potluri, Nalini, Anderson, Christine, Black, Hailey Findlay, Anderson, Lisa M., Gordon, Benjamin, Southwell, Amber L., Hayden, Michael R.

    Published in Neurobiology of disease (01-05-2022)
    “…Huntington disease (HD) is a neurodegenerative disease caused by a trinucleotide repeat expansion in the HTT gene encoding an elongated polyglutamine tract in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models by Joachimiak, Paweł, Ciesiołka, Adam, Kozłowska, Emilia, Świtoński, Paweł M, Figura, Grzegorz, Ciołak, Agata, Adamek, Grażyna, Surdyka, Magdalena, Kalinowska-Pośka, Żaneta, Figiel, Maciej, Caron, Nicholas S, Hayden, Michael R, Fiszer, Agnieszka

    Published in BMC biology (01-02-2023)
    “…The majority of genes in the human genome is present in two copies but the expression levels of both alleles is not equal. Allelic imbalance is an aspect of…”
    Get full text
    Journal Article
  10. 10

    Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity by Lemarié, Fanny L., Caron, Nicholas S., Sanders, Shaun S., Schmidt, Mandi E., Nguyen, Yen T.N., Ko, Seunghyun, Xu, Xiaohong, Pouladi, Mahmoud A., Martin, Dale D.O., Hayden, Michael R.

    Published in Neurobiology of disease (01-10-2021)
    “…Huntington disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HTT gene that codes for an elongated polyglutamine tract in the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease by Wright, Galen E B, Caron, Nicholas S, Ng, Bernard, Casal, Lorenzo, Casazza, William, Xu, Xiaohong, Ooi, Jolene, Pouladi, Mahmoud A, Mostafavi, Sara, Ross, Colin J D, Hayden, Michael R

    Published in Human molecular genetics (29-09-2020)
    “…Abstract Huntington disease (HD) is a neurodegenerative disorder that is caused by a CAG repeat expansion in HTT. The length of this repeat, however, only…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range by Findlay Black, Hailey, Wright, Galen E. B., Collins, Jennifer A., Caron, Nicholas, Kay, Chris, Xia, Qingwen, Arning, Larissa, Bijlsma, Emilia K., Squitieri, Ferdinando, Nguyen, Huu Phuc, Hayden, Michael R.

    Published in Genetics in medicine (01-12-2020)
    “…Purpose In some Huntington disease (HD) patients, the “loss of interruption” (LOI) variant eliminates an interrupting codon in the HTT CAG-repeat tract, which…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions by Caron, Nicholas S, Hung, Claudia L, Atwal, Randy S, Truant, Ray

    Published in Human molecular genetics (01-05-2014)
    “…Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder that can be characterized by the presence of protein inclusions containing…”
    Get full text
    Journal Article
  20. 20

    DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease by Schmidt, Mandi E, Caron, Nicholas S, Aly, Amirah E, Lemarié, Fanny L, Dal Cengio, Louisa, Ko, Yun, Lazic, Nikola, Anderson, Lisa, Nguyen, Betty, Raymond, Lynn A, Hayden, Michael R

    Published in Frontiers in cellular neuroscience (05-11-2020)
    “…Huntington disease (HD) is a devastating neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. Disrupted cortico-striatal…”
    Get full text
    Journal Article